Reversibility of pharmacodynamic effects after short and long-term treatment with tofacitinib in patients with rheumatoid arthritis. Genovese, M. C., Kawabata, T. T., Soma, K., Menon, S., Clark, J. D., Hodge, J. A., Takiya, L., Riese, R., Krishnaswami, S. WILEY-BLACKWELL. 2014: E225–E226

View details for Web of Science ID 000342916800144